Skip to main content
International Journal of Molecular Sciences logoLink to International Journal of Molecular Sciences
. 2020 Jan 13;21(2):499. doi: 10.3390/ijms21020499

Antimicrobial Chitosan Conjugates: Current Synthetic Strategies and Potential Applications

Yukun Qin 1,2,*, Pengcheng Li 1,2,*
PMCID: PMC7013974  PMID: 31941068

Abstract

As a natural polysaccharide, chitosan possesses good biocompatibility, biodegradability and biosafety. Its hydroxyl and amino groups make it an ideal carrier material in the construction of polymer-drug conjugates. In recent years, various synthetic strategies have been used to couple chitosan with active substances to obtain conjugates with diverse structures and unique functions. In particular, chitosan conjugates with antimicrobial activity have shown great application prospects in the fields of medicine, food, and agriculture in recent years. Hence, we will place substantial emphasis on the synthetic approaches for preparing chitosan conjugates and their antimicrobial applications, which are not well summarized. Meanwhile, the challenges, limitations, and prospects of antimicrobial chitosan conjugates are described and discussed.

Keywords: chitosan, conjugates, synthetic approach, antimicrobial activity, applications

1. Introduction

Chitosan, a product of the partial deacetylation of chitin, is a natural cationic linear polysaccharide. It has been recognized as one of the most promising renewable biopolymers due to its nontoxic, biodegradable, and biocompatible properties [1,2,3,4]. Chitosan possesses multiple activities such as antimicrobial, anti-oxidation, antiviral, and antitumor activities, among which its antimicrobial activities have attracted much attention in recent years [5,6,7,8]. It has been well documented that chitosan exhibits broad-spectrum antimicrobial activity [9,10]. It can inhibit the growth of a variety of fungi, bacteria and yeast [11]. Therefore, chitosan has broad application prospects in the fields of medicine, food, agriculture and so on [12,13].

However, the relatively poor antimicrobial properties of chitosan, as well as its low solubility in physiological environments, hinder its practical application [4,14]. In view of chitosan as an amino polysaccharide, the presence of reactive amino groups and hydroxyl groups makes it easy to chemically modify. Consequently, in recent years, many efforts have been made to functionalize chitosan to improve both its solubility and activity [15,16,17,18]. Extensive studies have proved that structural modification strategies such as quaternization [19], carboxylation [20], alkylation [21,22], and biologically active molecule conjugation [23,24] are very effective methods for obtaining more desirable chitosan derivatives.

One of the most attractive modification strategies is the attachment of bioactive substances to chitosan via covalent bonds. Such conjugation may maintain the fundamental properties of chitosan, enhance its solubility, and endow it with new properties ascribed to small active molecules [25,26]. In fact, polymer-drug conjugates have long been proven to be an effective form for improving the therapeutic effect and biological effect of a given drug [27,28,29], mainly in the following: (a). The hydrophobic drug is combined with the hydrophilic polymer to significantly improve the stability of the aqueous solution of the drug; (b). Triggering drug release for drug delivery; (c). Improving drug bioavailability and body fluid circulation time; (d). Avoiding drug degradation failure. According to the polymer conjugate model proposed by Ringsdorf, a chemical bond or tether formed by responses to a stimulus (pH, temperature, enzyme, etc.) is attached to the polymer backbone—if necessary, a targeting group or another group that alters the physical properties of the drug is introduced [30].

For chitosan conjugates, the basic composition of the complete chitosan-based conjugate system mainly includes active molecules (small molecule drugs, natural compounds, proteins/peptides, nucleic acids, etc.), chitosan carriers, coupled bonds or tethers. Sometimes, a solubilizing moiety or linker is needed. Based on this conjugation strategy, active ingredients such as caffeic acid [31], ferulic acid [32], tannic acid [33], catechin [34], curcumin [35], eurycomanone [36], streptomycin [37], gibberellin [38], cysteine [39], lysozyme [40], levofloxacin [41], cefuroxime [42] were reported to succeed in coupling with chitosan.

In the past decade, there have been extensive research reports on polysaccharide conjugates, and there have been some good review articles [43,44]. However, specifically regarding antimicrobial chitosan conjugates, there are currently very few review articles. It is obvious that the current covalent methodologies for chitosan conjugates and their potential applications in antimicrobial properties have not been well concluded and summarized.

Hence, this article will place substantial emphasis on the conjugation approach of chitosan conjugates and their antimicrobial applications, which have not been covered in the past 10 years. At the same time, we will also describe and forecast the challenges and problems in the current research and application of chitosan conjugates.

2. Methodologies for Covalent Bioactive Substances

Since 2000, there have been sporadic reports on the antimicrobial activities of chitosan conjugates, but there was little research in this area throughout the 2000 s. It was not until 2010 that chitosan conjugates used for antimicrobials attracted increasing attention. In the past three years, related research has experienced explosive growth, as shown in Figure 1A. Moreover, it was found that the coupling strategy of chitosan conjugates is generally through the coupling of natural products such as polyphenols [45], organic acids [46], and proteins/polypeptides such as lysozyme [47] or through the coupling of commercially available antimicrobials such as gibberellin [38], and sulfadiazine [48] (Figure 1B). Due to the diversity of coupled active molecular structures, their corresponding coupling methods are also different. Below, we will discuss and summarize the coupling methods in detail.

Figure 1.

Figure 1

Number of publications searched containing “antimicrobial chitosan conjugate” keywords via ISI Web of Science (A); Classification and proportion of corresponding chitosan conjugates (B); Note: The data for 2019 are as of the end of November.

2.1. Free Radical-Induced Conjugation

The free radical-induced conjugation method is commonly used in the synthesis of chitosan polyphenol conjugates due to its economical, convenient, and eco-friendly properties. Polyphenols are secondary metabolites of plants and are usually found in fruits, vegetables, teas and coffees. The most common phenolic substances are phenolic acids, flavonoids, stilbenes, and lignans [49]. These compounds are involved in various physiological activities including nutrient intake, protein synthesis, photosynthesis, etc. More importantly, it has been extensively proven that polyphenols possess good antimicrobial, antioxidant and other activities, which have been attracted increasing interest in recent years [50,51,52,53].

For the synthesis of conjugates between phenolic acids and chitosan, the free radical reaction is often initiated by the H2O2/VC system [45,54,55,56,57,58]. This system has several advantages. First, no toxic intermediates or products are generated during the reaction. Moreover, the reaction conditions are mild, and usually only need to be carried out at relatively lower temperatures, thereby reducing the possible decomposition of polyphenol active ingredients under higher temperature conditions. However, the diversity and complexity of the chitosan conjugate structure also put forward higher requirements for its structural characterization. In addition to conventional NMR, IR, and other methods, electron paramagnetic resonance (EPR) has also been demonstrated to play a key role in studying the mechanism of free radical grafting reaction of chitosan [59,60,61,62]. This is because EPR spectroscopy is useful for elucidating the species of free radicals present in a reaction and distinguishing carbon, nitrogen or oxygen-based free radicals.

The proposed mechanism is shown in Figure 2. First, ascorbic acid reacts with hydrogen peroxide at room temperature to produce hydroxyl and ascorbate free radicals. Afterwards, the generated hydroxyl radical captures hydrogen atoms on the polysaccharide chain -OH, and -NH2 groups to activate the chitosan to form a chitosan radical. Finally, the polyphenol serves as an acceptor and reacts with the chitosan radical to form a chitosan polyphenol conjugate [33,57].

Figure 2.

Figure 2

Proposed mechanism of synthesis of polyphenol chitosan conjugate by free radical induction reaction.

Since the degree of substitution (DS) of the conjugate is a key factor affecting its activity, many recent studies have focused on increasing the DS by optimizing the reaction conditions [54,55,57,58,63]. Some studies have shown that by increasing the ratio of polyphenols to chitosan in the critical range, the polyphenol content in the conjugate can be increased. However, beyond that range, excessive free polyphenol molecules may inhibit the progress of the reaction, resulting in a decrease in the coupling rate [54,63]. Therefore, although the radical reaction has advantages such as being green and economical, its low derivatization degree is an urgent problem to be solved, and thus other functionalization strategies such as chemical condensation, enzyme-assisted, and electrochemical methods have been gradually explored.

2.2. Carbodiimide Chemistry

The free amino and hydroxyl groups present in the chitosan molecule may undergo acylation and esterification reactions. Synthetic methods commonly used in such reactions include an acyl chloride method, a mixed acid anhydride method, an activated ester method, and a carbodiimide method. For example, İlyasoğlu and Guo reported the synthesis of soluble chitosan-caffeic acid conjugates. First, caffeic acid reacted with SOCl2 to form an acyl chloride, which then reacts with a free amino or hydroxyl group of chitosan to form an amide bond and an ester bond, respectively. The addition of dimethyl aminopyridine (DAMP) as a catalyst can promote the reaction of acyl chlorides and amino groups [31]. However, the disadvantage of this method is that acyl chloride is formed under acidic conditions and that many acid-sensitive groups cannot withstand it. To avoid degradation of chitosan and loss of its biological activity, crosslinking of biologically active molecules with chitosan should be carried out using mildly reactive reagents under mild conditions (e.g., near-neutral pH, room temperature, aqueous solution). Carbodiimide is an ideal reagent for satisfying the above reaction conditions and thus has been widely used in the synthesis of chitosan conjugates [32,38,46,64,65,66,67,68,69,70,71,72,73]. Currently, there are three main types of condensing agents: dicyclohexylcarbodiimide (DCC) and diisopropylcarbodiimide (DIC), and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC). The use of such a condensing agent generally requires the addition of an acylation catalyst or an activator including 4-N,N-lutidine (DMAP), 1-hydroxybenzotriazole (HOBt), N-hydroxysuccinimide (NHS) etc. The carbodiimide condensation reagent method is currently the most widely used method for forming an amide bond and is also widely used in the construction of ester bonds, macrolactams and lactones. In this method, the carboxyl component and the amino component are usually mixed, and the intermediate is directly reacted to form an amide bond without separation by the action of a condensation reagent. Thus, it is not necessary to prepare a carboxyl-activated intermediate such as an acyl halide, acid anhydride or activated ester in advance, which is not only simple and efficient, but can also effectively avoid some side reactions generated during separation and purification of the activated intermediate and storage.

The earliest carbodiimide condensation reagent used was N,N-dicyclohexylcarbodiimide (DCC) [74]. However, the dicyclohexylurea (DCU) formed by the reaction has limited solubility in most organic solvents and is difficult to remove. At present, the commonly used carbodiimide chemistry is the EDC/NHS system (Figure 3). The proposed mechanism of the reaction is as follows: First, the carboxylic acid group is activated by EDC to produce an O-acylisourea group; then it is converted into a more stable active NHS-activated carboxylic acid group, and finally coupled with the amino group of chitosan to form the chitosan conjugates [75]. One of the main characteristics of this process is that the urea formed after the reaction is water-soluble and can be easily washed off. Due to the mild reaction conditions and simple workup process, this approach has become one of the preferred methods for the synthesis of chitosan conjugates. However, the reaction selectivity of EDC is not very good, it can react with the amino groups of chitosan and hydroxyl groups. Therefore, functional group protection is required to ensure accurate synthesis of chitosan conjugates [73]. However, the reality is that most of the current studies have not adopted a strategy of functional group protection.

Figure 3.

Figure 3

Proposed mechanism of synthesis of a chitosan conjugate by a carbodiimide based chemical coupling method.

2.3. Coupling by Forming a Schiff Base

Among the diverse chitosan conjugates, imine-linked chitosan conjugates have recently received considerable attention. The primary amino group contained in the chitosan skeleton can easily undergo a condensation reaction with an acyl compound (aldehyde, ketone) to form a Schiff base [76,77,78,79,80,81]. This reaction can be performed in a green solvent such as water and ethanol, and the reaction conditions are mild and green. No toxic reagents are introduced during the reaction. More importantly, this reaction is a specific reaction between amino and acyl groups. During the reaction, no side reactions will occur with the free hydroxyl groups of chitosan. Therefore, the reaction has the advantages of good regioselectivity and environmental friendliness. It has been reported that galactose [82], curcumin [35], inulin [83], and caffeic acid [84] can be successfully coupled with chitosan to obtain the corresponding conjugates by this method. It should be noted that, considering the instability of the Schiff base, the chitosan Schiff base conjugate is usually reduced to a stable amino-substituted chitosan conjugate through sodium borohydride or sodium cyanoborohydride [37,85,86].

2.4. Functional Group Conversion Strategy

Although the presence of hydroxyl and amino groups in the chitosan molecule can allow structural modification to be easily carried out, in terms of conjugates that result in chitosan conjugates with more structural diversity, it is very necessary to explore a functional group conversion strategy to introduce new reactive groups to the chitosan backbone. It has been demonstrated that the amino group of chitosan can be converted into azide group [87], substituted carboxyl group [88], substituted mercapto group [89], etc., and the hydroxyl group can be azidated [90], aminated [91,92], oxidized to an aldehyde [93] or carbonyl group [94], or further oxidized to a carboxyl group [95]. Figure 4 lists some common functional group conversion methods used in the preparation of common chitosan conjugates. For example, the 2,3-diols of chitosan can be oxidized by NaIO4 to form partially oxidized chitosan [94]. Chitosan anhydro-D-mannofuranose can be obtained by nitrous acid depolymerization of chitosan [93]. Recently, Barbosa et.al. developed a method for preparing azide chitosan using imidazole-1-sulfonyl azide hydrochloride, which avoided the use of unstable and explosive azide reagents such as azide ions and triflyl azides [96]. It should be pointed out that some functional group conversion strategies such as introducing spacer arms-bearing active groups into chitosan can not only increase the reaction site, but also reduce the crowding effect, increase the reactivity, reduce steric hindrance, and improve the coupling rate and other functions. The use of spacer arms can enhance the binding of ligands to polysaccharides and provide a variety of binding sites. To date, functionalized chitosan with new reactive groups such as aldehyde groups, carbonyl groups, carboxyl groups, and thiol groups have been used widely for conjugations [82,97].

Figure 4.

Figure 4

Functional group conversion strategies commonly used in the synthesis of chitosan conjugates.

2.5. Enzyme-Assisted Coupling Reaction

Biological enzymatic conjugation of chitosan is mainly based on the catalytic oxidation of biological enzymes, which stimulates the grafting compound (generally a substrate of laccase) to form a highly reactive intermediate. The enzymes commonly used to modify chitosan are polyphenol oxidases, including tyrosinase [98], peroxidase [99], and laccase [100,101,102]. The grafted bioactive substances are mostly phenolic compounds such as cinnamic acid, ferulic acid and lauric acid.

The enzyme catalysis reaction mechanism of chitosan and phenolic compounds is not clear at present, but the prevailing view is that laccase and tyrosinase are used to catalyze the conversion of phenolic compounds to quinone, which is more reactive. A non-enzymatic reaction that undergoes a Schiff base or a Michael addition reaction with chitosan generates a chitosan-phenolic conjugate (Figure 5) [103,104].

Figure 5.

Figure 5

Proposed mechanism for the synthesis of polyphenol-chitosan conjugates through an enzyme-mediated strategy.

By catalysis with these biological enzymes, chitosan conjugates with new or better properties than the original chitosan can be obtained. This approach is expected to expand the application of chitosan in the pharmaceutical, cosmetics, and food industries. The biosynthesis method does not use any chemical reagents and has the advantages of good environmental compatibility, safety, and weak-side reactions. However, the method requires harsh reaction conditions. At the same time, the reaction will cause the hydroxyl group in the phenolic acid to be oxidized, which will reduce the activity of the synthetic product [105].

2.6. Other Methods

In the synthesis of chitosan conjugates, in addition to the above synthesis methods, other methods have also been reported in the literature. Examples include the Maillard reaction [106], acid-base salt formation reaction [36], and electrochemical reaction [107]. For instance, the Maillard reaction is commonly used for the coupling of xylan [108], polylysine [109], and lysozyme [47,106,110] with chitosan. The Maillard reaction is a non-enzymatic browning reaction, which occurs between the ε-amino group in a protein and the reducing carbonyl group in a polysaccharide upon heating. Generally, Maillard reactions follow a complex mechanism that is divided into three main phases (early, advanced, and final) [111]. Maillard-type protein-polysaccharide conjugates show potential applications because of their excellent and thermal stability, solubility and antimicrobial activity. Chitosan, coupled with lysozyme through the Maillard reaction, can also bring improved antibacterial activity and stability [110]. However, the Maillard reaction has a complex reaction mechanism, and the complexity of its conjugate structure poses challenges for precise structural analysis and repeatable synthesis.

Electrochemically assisted coupled reactions are also a method worthy of attention because of their environmental and safety advantages. For example, Kim et al. reported the successful fabrication of a chitosan-phenolic film via electrochemistry of catechol oxidation and putative chemistry [107]. However, so far, relatively few reports have investigated this type of method, and its reaction mechanism and procedure need to be further studied and optimized.

3. Physiochemical Properties, Antimicrobial Activities, and Potential Applications

3.1. Physiochemical Properties and Antimicrobial Activities

As mentioned above, there are various types of coupling methods for chitosan conjugates. Active molecules can be covalently bonded to chitosan backbone or linked to the chitosan molecule through a linker. So how to choose a suitable coupling method, process, regents, and linker are crucial for subsequent activity research and practical application. Generally, the ideal conjugating approach should ensure a high yield of the conjugate, a uniform composition of the conjugate, a suitable binding ratio, maximum biological activity, convenient operation, and easy purification. More examples of chitosan conjugate systems were listed in Table 1.

Table 1.

Representative chitosan conjugate systems.

Number Sample Active Molecule Linker Bond Type References
1 Chitosan-tannic acid: Conjugate tannic acid No Amide/ester [33]
2 Gallic acid-chitosan conjugate gallic acid No Amide/ester [55]
3 Chitosan–hydroxycinnamic acid conjugates hydroxycinnamic acid No Amide/ester [54]
4 Gibberellin–chitosan conjugate gibberellin No Amide [38]
5 Chitosan-caffeic acid conjugates caffeic acid No Amide [31]
6 Curcuminconjugated chitosan curcumin No Imino [35]
7 Chitosan-isoniazid conjugates isoniazid epichlorohydrin Hydrazo/hydrazide [112]
8 Chitosan–thymine conjugate thymine bromoacetic acid Amide [74]
9 chitosan-PVC conjugates PVC bromoacetyl bromide Alkylamino [97]

With the construction of the chitosan coupling system, the physical and chemical properties of chitosan, including thermal stability, solubility, crystallinity, etc., will generally change accordingly: (1) Thermal stability. The thermal stability of the chitosan conjugate is closely related to polysaccharides and bioactive substances. Some studies have shown that the introduction of exogenous active substances can lead to a decrease in the thermal stability of chitosan, which may be due to the weakening of the strong intramolecular bonding in the chitosan chain and the obstruction of chitosan chain packing due to the coupling reaction [41,74,113]. This decrease in thermal stability usually does not affect the actual application of chitosan, because the structural modification only partially reduces the thermal stability of chitosan, and its conjugates still have high thermal stability (usually up to 200 °C) [113]. Even more exciting is that due to the decrease in the intramolecular force of chitosan, its solubility is improved instead [31]. (2) Solubility. Modification of chitosan often significantly improves its water solubility [25,31,114]. This is because the introduction of bioactive groups reduces the force of intramolecular hydrogen bonding interactions within chitosan. The steric hindrance is increased due to the aggregation of polysaccharide chains. In addition, small active molecules such as phenolic acid groups contain many hydroxyl groups to enhance the interaction between the conjugate and water. (3) Crystallinity. The coupling reaction often reduces the crystallinity of chitosan conjugates [69,74]. This may be due to the intra- and intermolecular hydrogen bonding interaction of chitosan being destroyed after the reaction, which is consistent with the abovementioned decrease in the thermal stability of chitosan.

In addition to the changes in physicochemical properties brought about by the chitosan coupling strategy, more interesting is the improvement of the antimicrobial activity of chitosan. Although it has been demonstrated that chitosan displays broad-spectrum antimicrobial activities against gram-positive bacteria, gram-negative bacteria and fungi, it is true that relatively poor activity of chitosan hinders its practical application. Compared with chitosan itself, the chitosan conjugates can have improved the antimicrobial properties of chitosan, as well as the improved poor water solubility of chitosan, which allowing the conjugates can to be used in neutral environments. For example, Lee et al. reported the synthesis of chitosan–caffeic acid, chitosan–ferulic acid (CFA), and chitosan–sinapic acid conjugates with enhanced antimicrobial activity against Staphylococcus aureus and foodborne pathogens. Among the chitosan conjugates, the MIC values of the CFA is in range of 32–64 μg/mL, which is much lower than that of unmodified chitosan [54]. Wang et al. described the antimicrobial properties of different chitosan phenolic acids conjugates. It was found that all the chitosan conjugates exhibited significantly higher antimicrobial activities. Moreover, it was reported by Lee and Je that gallic acid conjugated chitosan displayed much better antibacterial activities than unmodified chitosan, of which the MIC value ranged from 16 to 64 μg/mL against the tested bacteria. Interestingly, it was thought that gallic acid in the chitosan conjugate does not exert major antibacterial activity, and there may be synergistic effects of phenolic acid and CS through conjugation [115]. Similar results have also been reported by two other labs [37,86], suggesting that the coupling of chitosan and streptomycin may play a synergistic effect. In general, chitosan conjugates generally have a broader spectrum and higher antimicrobial activity than chitosan. However, their antimicrobial properties can be affected by multiple factors such as strains, pH values, and degree of substitution, so it is necessary to further study the activity and mechanism. More antimicrobial data on chitosan conjugates can be found in Table 2.

Table 2.

Antimicrobial activities of representative chitosan conjugates.

Sample Microorganism Antimicrobial Properties References
Chitosan-Catechin
Conjugate
Bacillus subtilis MIC: 64 μg/mL (Conjugate); 128 μg/mL (chitosan) [34]
Chitosan-Caffeic
Acid Conjugate
Staphylococcus aureus MIC: 8 μg/mL (Conjugate); 16 μg/m(chitosan) [116]
Chitosan–hydroxycinnamic acid conjugates Bacillus subtilis MIC: 2 μg/mL (CFA (I)); 128 μg/mL(chitosan) [54]
Chitosan thiolated conjugate E. coli MIC: 2.9 mg/mL (TCNAC); 4.1 mg/mL(chitosan) [39]
Chitosan thiolated conjugate Bacillus subtilis MIC: 0.25 mg/mL (CA-g-CS); 2 mg/mL(chitosan) [69]
chitosan–lauricacid conjugate Staphylococcus aureus Antibacterial rate: 95.6% (Ti-PDOP-Chi–2.5%LA) [117]
Cinnamic acids conjugated chitosan Ralstonia solanacearum−5 IC50: 0.23 mg/mL (CTS-g-CA)); 0.56 mg/mL(chitosan) [118]
Chitosan gallic acid conjugate C. albicans Reduction of fungi: 70%(GA); 61%(chitosan) [100]
Sulfadiazine—Chitosan Conjugates Listeria monocytogenes Inhibition rate: 100% (PEC Lm-SDZ); 58%(chitosan) [48]
Polylysine–chitosanconjugates Beer yeast Inhibition zone: 1.36 cm (conjugate)
0.96 cm (chitosan)
[109]
Hydrocaffeic acid conjugated chitosan S. epidermidis Enhanced antimicrobial activity compared to pure chitosan. [119]

3.2. Potential Applications

Chitosan is favoured by scientific researchers for its wide potential application in different fields. After modification, the advantages of chitosan such as good biocompatibility and non-toxicity are maintained, and the water solubility and antimicrobial activity are enhanced (Table 3). In addition to the physiochemical parameters mentioned above, during modification of the chitosan structure, other physical and chemical properties such as viscosity, emulsification performance, and mechanical strength may also change accordingly, as shown in Table 3. As a result, the newly synthesized chitosan conjugate has many new properties that are different from that of chitosan.

Table 3.

Physicochemical properties, bio-functions, cytoxicity and potential applications of the typical chitosan conjugates *.

Sample Potential Applications Physiochemical Properties Bio-Functions Cytotoxicity References
LED 209 conjugated chitosan Antimicrobial and anti-adhesion material Increasing solubility with increase in DS Highly selective activity and anti-adhesion activity against MDR-E. coli Minor cytotoxicity to mammalian cells. [114]
Galabiose-chitosan Conjugate Anti-adhesion agents Showed good solubility in neutral water
(1.0 mg/mL)
The highest inhibitory effect at the DP of 1839 (MIC:1.7 nM) n.d [120]
Gibberellin–chitosan Fungicide release Good water solubility and stability n.d n.d [38]
Dhvar-5-chitosan conjugate Antimicrobial surfaces lower viscosity values Displayed bactericidal effect. No cytotoxic potential. [96]
Curcumin conjugated chitosan Anti-skin infection agent n.d Be effective against
E. coli and S. Auerus
Cyto and hemo-compatible [35]
Inulin–LCS Conjugate Anti-biofilm reagent Good water solubility Showed similar biofilm eradication with florfenicol at 500 μg/mL Low cellular toxicity to mammalian [83]
Gallic acid-grafted-chitosan Biomaterials in food packaging An increase in water solubility; exhibited darker appearance and weaker transmittance Significantly enhanced antibacterial ability n.d [72]
Gallic acid grafted chitin-glucan complex Biomedical areas n.d Completely inhibited the growth of Bacillus subtilis and Escherichia coli Non-hazardous and biocompatible
Chitosan–hydroxycinnamic acid conjugates Food and pharmaceutical industries n.d Exhibited better antimicrobial activity than chitosan No cytotoxic activity [56]
Chitosan–lysozyme conjugates Ingredient with emulsifying properties Greatly improved solubility and emulsion stability Enhanced bactericidal action against Escherichia coil K-12, n.d [54]
lysozyme-chitosan oligosaccharide conjugates Refractory infection drugs n.d Exhibited antibacterial activity and low drug resistance Low hemolytic activity [110]
Cefuroxime conjugated chitosan Anti-chronic wound infection drugs Decrease in the rate of swelling and degradation rate Showed an efficient antibacterial activity over a longer period. Have good blood compatibility [106]
Chitosan-phenolic acid conjugates Food preservatives Improved water solubility Showed broad spectrum antibacterial activity n.d [42]
Chitosan-isoniazid conjugates Antituberculosis drugs Enhanced solubility under physi-ological conditions Comparable or slightly higher minimum inhibitory concentration for conjugates than for INH itself Reduced biodegradability and decreased toxicity [121]
Proanthocyanidin-chitosan conjugate Food nutraceutical, and Biomedicine filed Had lower crystallinity and thermal stability than chitosan Showed bacterial strain-depended behavior in the antibacterial activity compared with chitosan n.d [112]

*: n.d.—not determined.

The special properties of disinfection and promotion of wound healing of the chitosan conjugate make it very potential for development as an antimicrobial agent. The chitosan conjugates have shown great application prospects in artificial skin, wound dressing materials and antimicrobial surfaces. For example, Zhou et al. synthesized a class of chitosan LED209 conjugates based on chemical coupling method. Compared with chitosan, the conjugates displayed better solubility and higher selectivity for MDR-E. coli. Further studies have shown that the conjugates can maintain the characteristics of CS and LED 209, and prevent bacterial adhesion. Therefore, these findings provide a feasible strategy for the synthesis of multifunctional antibacterial agents [114]. Mu et al. successfully combined chitosan with streptomycin, thereby improving the ability of antibiotics to resist biofilms formed by gram-positive bacteria rather than gram-negative bacteria, and thus providing a new solution to the problem of antibiotic resistance. In this study, a robust nanoparticle was developed by introducing gold (Au) nanoparticles into a chitosan-streptomycin conjugate (CS), with the product called CA NPs. It was proved that the nanoparticles have a strong double-membrane destruction activity against gram-negative bacteria (Figure 6) [37].

Figure 6.

Figure 6

Effect of CA NPs on prefabricated biofilms formed by gram-negative and gram-positive organisms. Biofilm produced by Pseudomonas aeruginosa (A), Salmonella typhimurium (B), Listeria monocytogenes (C), and Staphylococcus aureus (D) treated with CA NPs (250 mg/mL), CS (250 mg/mL), streptomycin (Strep, 50 mg/mL) for 24 h; After 24 h of treatment, pre-formed biofilm structures of Pseudomonas aeruginosa (E) and Staphylococcus aureus (F) under a fluorescence microscope (Scale bar represented for 10 μm); After 24 h of treatment, pre-formed biofilm structures of Pseudomonas aeruginosa (G) and Staphylococcus aureus (H) under a scanning electron microscopy (Scale bar represented for 400 nm). Reprinted with permission from [37].

Another antimicrobial application of chitosan conjugates is as a carrier for antibiotics. As a natural high-molecular-weight polymer, chitosan is widely used in drug delivery systems, especially anti-cancer drugs. In chitosan-drug combination systems, chitosan and drugs form conjugates, which can achieve targeted delivery and controlled release of drugs, thereby improving bioavailability and treatment efficacy. However, in terms of bacteriostatic applications, only a few studies have been conducted on coupling chitosan with antibacterial drugs for drug release [41,48]. The current research focus of chitosan conjugates is mainly focused on the coupling of chitosan with natural antibacterial substances and their applications as external antibacterial materials. For example, Xu et al. described the synthesis of a new type of thermo-responsive chitosan–catechol–pNIPAM wet adhesive conjugate. The synthesized chitosan conjugates have reversible sol-gel transition behaviour and thermally responsive wet adhesion. By taking advantage of these outstanding features, the conjugates can achieve controlled attachment/detachment behaviour on the skin through heating/cooling processes. Moreover, this material is expected to be used as an intelligent adhesive in various biomedical environments [67].

The film-forming properties of chitosan can also allow it to be applied to food packaging and preservation. In addition to serving as a protective barrier, the edible chitosan films can be used as a carrier for bioactive compounds to improve food quality. The combination of chitosan and different antimicrobial agents, such as organic acids, plant extracts, antibiotics, etc., can reduce food spoilage of pathogenic microorganisms and extend shelf life [45,63,121].

As mentioned above, chitosan conjugates have many excellent properties and have broad antimicrobial application prospects in the pharmaceutical and food industries. Chitosan conjugates, like chitosan, have inherent advantages in preventing wound infection and promoting wound healing due to their good biocompatibility and low toxicity. This greatly enhances the application value of chitosan derivatives and provides more options for preparing biocompatible and non-toxic antimicrobial agents.

4. Challenge and Limitations

4.1. How Can Chitosan Conjugates Be Properly Designdesigned and Synthesized to Ensure Their Effectiveness?

As mentioned above, there are many types of chitosan coupling and cross-linking methods, each with their own advantages and disadvantages. Determining how to properly design the chitosan conjugate and select the appropriate coupling method is a challenge in itself. When evaluating a conjugating method, the following relevant factors should be considered: (a) The effect of the coupling reaction, such as being a green synthesis method and having easy post-processing, the homogeneity of the composition of the conjugates; (b) The yield of the conjugation reaction and the degree of substitution (DS) of the conjugates; (c) The effect of the coupling process on the biological activity; and (d) Clear application objects and scope. Overall, the ideal conjugating method should ensure a high yield of the conjugate, a uniform conjugate composition, a suitable binding ratio, maximum biological activity, convenient operation, and easy purification; moreover, under the same conditions, the method should have good repeatability. In the preparation of the conjugate, it is also required that the prepared conjugate maintain the structural specificity of the original active substance; the conjugating method used should not significantly change the original structure or introduce toxic groups.

The following points are specifically emphasized: It is generally believed that the higher the DS of the chitosan conjugate is, the stronger its antibacterial activity is [114]. However, due to the structure of the chitosan macromolecule and its potential steric hindrance, the coupling rate of chitosan is not high in many cases [33,57,63], which may bring the problem of the insufficient effective concentration of active ingredients in the body. Another very important issue is that macromolecular conjugates are first required to be able to provide quantitative or targeted sustained release of free biologically active drugs in vivo. To this end, the coupling bond that connects the drug to the carrier must be able to dissociate at a certain rate under a physiological environment. Moreover, the introduction of chemically linked fragments or reactive groups during the construction of the materials results in not all the chitosan-based conjugates exhibiting good biodegradability and compatibility, and conversely, even producing toxic side effects [112].

Therefore, an appropriate coupling method must be selected according to the purpose of the conjugate and the advantages and disadvantages of different methods must be weighed. Reasonable conjugate design is the premise to ensure its safety and effective therapeutic effect.

4.2. How Can the Structure-Activity Relationship and Mechanism of Action of the Chitosan Conjugates Be Clarified?

The antimicrobial activities of chitosan, as a class of biological macromolecules, are affected by many factors including molecular weight, degree of deacetylation, pH, etc. [122,123,124]. There are often large differences in antimicrobial activity in different studies, and some studies even obtained diametrically opposite results, which makes it a great challenge to accurately evaluate the structure-activity relationships. Therefore, although the introduction of active ingredients on the chitosan sugar chain improves its activity, it also brings more complexity to the structure and results in greater challenges determining the structure-activity relationship and antimicrobial mechanisms. In addition, the covalent bonding of the active ingredient to the chitosan carrier is usually a random process. Selecting the reaction site of the active ingredient in the sugar chain remains an uncontrollable problem. What is more important—How to clarify the functional differences between chitosan conjugates and chitosan and active ingredient mixtures? Is coupling necessary or redundant? Considering that chitosan conjugates are relatively complex systems that differ from traditional small molecules with a well-defined chemical structure, accurately characterizing their structure is a great challenge. The superposition of all the above factors brings great difficulties in studying the structure-activity relationships of chitosan conjugates.

The antimicrobial mechanism of chitosan is still controversial. It may have different modes of action against gram-positive bacteria, gram-negative bacteria and fungi [122]. At present, the generally accepted view is that the electrostatic interactions between the protonated amino group of the chitosan molecule and the anionic surface of the pathogen under acidic conditions are the key to determining the chitosan antimicrobial mechanism. The introduction of active molecules can improve its antimicrobial properties as well as increase its water solubility and expand its application range. However, the diversity of the chitosan conjugate structure influences the complexity of its antimicrobial mechanism. Does the chitosan conjugate work as a system or does it work by slow-releasing active ingredients? What role does chitosan play in this process? Is it just a carrier? There are still many questions that need to be studied and answered.

5. Conclusions and Outlook

In the past decade, great progress has been made in the study of chitosan conjugates. Many chitosan conjugates with diverse structures and functions have been synthesized and show potential application prospects. However, at present, there is no clear mechanism for the antimicrobial effect of chitosan and its conjugates. Moreover, studies on chitosan conjugates are mostly focused on their physicochemical properties and in vitro antimicrobial effects, which delays their practical applications. Therefore, the progress and continuous development of chitosan conjugate research urgently require the multi-disciplinary and multi-collaborative collaboration of polymer chemists, medicinal chemists, and pharmaceutical scientists. It is believed that with the rapid development of cell biology, molecular biology, materials chemistry and nanotechnology, chitosan conjugates will play a greater role in antimicrobial therapy.

Author Contributions

P.L. put forward the ideas of the paper, and Y.Q. wrote the paper and processed the diagrams. Both the authors approved the final version of the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This article is supported by the National Key R&D Program of China (2018YFC0311305, 2019YFD0900705), the Key Research and Development Program of Shandong Province (2018GHY115017, 2018GHY115008, 2019GHY112015), Qingdao Applied Basic Research Project (19-6-2-34-cg), and Science and technology program of Nantong (MS120170234).

Conflicts of Interest

The authors declare no conflict of interest.

References

  • 1.Muxika A., Etxabide A., Uranga J., Guerrero P., De La Caba K. Chitosan as a bioactive polymer: Processing, properties and applications. Int. J. Boil. Macromol. 2017;105:1358–1368. doi: 10.1016/j.ijbiomac.2017.07.087. [DOI] [PubMed] [Google Scholar]
  • 2.Younes I., Rinaudo M. Chitin and Chitosan Preparation from Marine Sources. Structure, Properties and Applications. Mar. Drugs. 2015;13:1133–1174. doi: 10.3390/md13031133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Halim A.S., Periayah M.H., Saad A.Z.M. Chitosan: A promising marine polysaccharide for biomedical research. Pharmacogn. Rev. 2016;10:39–42. doi: 10.4103/0973-7847.176545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Pillai C., Paul W., Sharma C.P. Chitin and chitosan polymers: Chemistry, solubility and fiber formation. Prog. Polym. Sci. 2009;34:641–678. doi: 10.1016/j.progpolymsci.2009.04.001. [DOI] [Google Scholar]
  • 5.Cheung R.C.F., Ng T.B., Wong J.H., Chan W.Y. Chitosan: An Update on Potential Biomedical and Pharmaceutical Applications. Mar. Drugs. 2015;13:5156–5186. doi: 10.3390/md13085156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kumar M.N.V.R., Muzzarelli R.A.A., Muzzarelli C., Sashiwa H., Domb A.J. Chitosan Chemistry and Pharmaceutical Perspectives. Chem. Rev. 2004;104:6017–6084. doi: 10.1021/cr030441b. [DOI] [PubMed] [Google Scholar]
  • 7.Lunkov A.P., Ilyina A.V., Varlamov V.P. Antioxidant, Antimicrobial, and Fungicidal Properties of Chitosan Based Films (Review) Appl. Biochem. Microbiol. 2018;54:449–458. doi: 10.1134/S0003683818050125. [DOI] [Google Scholar]
  • 8.Sahariah P., Másson M. Antimicrobial Chitosan and Chitosan Derivatives: A Review of the Structure–Activity Relationship. Biomacromolecules. 2017;18:3846–3868. doi: 10.1021/acs.biomac.7b01058. [DOI] [PubMed] [Google Scholar]
  • 9.Rabea E.I., Badawy M.E.T., Stevens C.V., Smagghe G., Steurbaut W. Chitosan as antimicrobial agent: Applications and mode of action. Biomacromolecules. 2003;4:1457–1465. doi: 10.1021/bm034130m. [DOI] [PubMed] [Google Scholar]
  • 10.Sigroha S., Khatkar A. Chitosan—A Naturally Derived Antioxidant Polymer with Diverse Applications. Curr. Org. Chem. 2017;21:333–341. doi: 10.2174/1385272820666161018130542. [DOI] [Google Scholar]
  • 11.Kong M., Chen X.G., Xing K., Park H.J. Antimicrobial properties of chitosan and mode of action: A state of the art review. Int. J. Food Microbiol. 2010;144:51–63. doi: 10.1016/j.ijfoodmicro.2010.09.012. [DOI] [PubMed] [Google Scholar]
  • 12.Ngo D.-H., Kim S.-K. Antioxidant Effects of Chitin, Chitosan, and Their Derivatives. Adv. Food Nutr. Res. 2014;73:15–31. doi: 10.1016/B978-0-12-800268-1.00002-0. [DOI] [PubMed] [Google Scholar]
  • 13.Yuan G., Chen X., Li D. Chitosan films and coatings containing essential oils: The antioxidant and antimicrobial activity, and application in food systems. Food Res. Int. 2016;89:117–128. doi: 10.1016/j.foodres.2016.10.004. [DOI] [PubMed] [Google Scholar]
  • 14.Zargar V., Asghari M., Dashti A. A Review on Chitin and Chitosan Polymers: Structure, Chemistry, Solubility, Derivatives, and Applications. ChemBioEng Rev. 2015;2:204–226. doi: 10.1002/cben.201400025. [DOI] [Google Scholar]
  • 15.El Knidri H., Belaabed R., Addaou A., Laajeb A., Lahsini A. Extraction, chemical modification and characterization of chitin and chitosan. Int. J. Boil. Macromol. 2018;120:1181–1189. doi: 10.1016/j.ijbiomac.2018.08.139. [DOI] [PubMed] [Google Scholar]
  • 16.Islam S.-U., Butola B. Recent advances in chitosan polysaccharide and its derivatives in antimicrobial modification of textile materials. Int. J. Boil. Macromol. 2019;121:905–912. doi: 10.1016/j.ijbiomac.2018.10.102. [DOI] [PubMed] [Google Scholar]
  • 17.Sajid M.A., Shahzad S.A., Hussain F., Skene W.G., Khan Z.A., Yar M. Synthetic modifications of chitin and chitosan as multipurpose biopolymers: A review. Synth. Commun. 2018;48:1893–1908. doi: 10.1080/00397911.2018.1465096. [DOI] [Google Scholar]
  • 18.Mourya V., Inamdar N.N. Chitosan-modifications and applications: Opportunities galore. React. Funct. Polym. 2008;68:1013–1051. doi: 10.1016/j.reactfunctpolym.2008.03.002. [DOI] [Google Scholar]
  • 19.Shinde U.A., Joshi P.N., Jain D.D., Singh K. Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery. Curr. Eye Res. 2019;44:575–582. doi: 10.1080/02713683.2019.1567793. [DOI] [PubMed] [Google Scholar]
  • 20.Rekha M.R., Sharma C.P. Simultaneous Effect of Thiolation and Carboxylation of Chitosan Particles Towards Mucoadhesive Oral Insulin Delivery Applications: An In Vitro and In Vivo Evaluation. J. Biomed. Nanotechnol. 2015;11:165–176. doi: 10.1166/jbn.2015.1904. [DOI] [PubMed] [Google Scholar]
  • 21.Popescu V., Muresan A., Popescu G., Balan M., Dobromir M., Balan-Porcarasu M. Ethyl chitosan synthesis and quantification of the effects acquired after grafting it on a cotton fabric, using ANOVA statistical analysis. Carbohydr. Polym. 2016;138:94–105. doi: 10.1016/j.carbpol.2015.11.009. [DOI] [PubMed] [Google Scholar]
  • 22.Mati-Baouche N., Delattre C., De Baynast H., Grédiac M., Mathias J.-D., Ursu A.V., Desbrières J., Michaud P. Alkyl-Chitosan-Based Adhesive: Water Resistance Improvement. Molecules. 2019;24:1987. doi: 10.3390/molecules24101987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Mu Y., Wu G., Su C., Dong Y., Zhang K., Li J., Sun X., Li Y., Chen X., Feng C. pH-sensitive amphiphilic chitosan-quercetin conjugate for intracellular delivery of doxorubicin enhancement. Carbohydr. Polym. 2019;223:115072. doi: 10.1016/j.carbpol.2019.115072. [DOI] [PubMed] [Google Scholar]
  • 24.Ding J., Xu Z., Qi B., Cui S., Wang T., Jiang L., Zhang Y., Sui X. Fabrication and characterization of soybean oil bodies encapsulated in maltodextrin and chitosan-EGCG conjugates: An in vitro digestibility study. Food Hydrocoll. 2019;94:519–527. doi: 10.1016/j.foodhyd.2019.04.001. [DOI] [Google Scholar]
  • 25.Hu Q., Luo Y. Polyphenol-chitosan conjugates: Synthesis, characterization, and applications. Carbohydr. Polym. 2016;151:624–639. doi: 10.1016/j.carbpol.2016.05.109. [DOI] [PubMed] [Google Scholar]
  • 26.Ryu J.H., Hong S., Lee H. Bio-inspired adhesive catechol-conjugated chitosan for biomedical applications: A mini review. Acta Biomater. 2015;27:101–115. doi: 10.1016/j.actbio.2015.08.043. [DOI] [PubMed] [Google Scholar]
  • 27.Greco F., Vicent M.J. Combination therapy: Opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. Adv. Drug Deliv. Rev. 2009;61:1203–1213. doi: 10.1016/j.addr.2009.05.006. [DOI] [PubMed] [Google Scholar]
  • 28.Kopeček J. Polymer-drug conjugates: Origins, progress to date and future directions. Adv. Drug Deliv. Rev. 2013;65:49–59. doi: 10.1016/j.addr.2012.10.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Xu H., Ma H., Yang P., Zhang X., Wu X., Yin W., Wang H., Xu N. Targeted polymer-drug conjugates: Current progress and future perspective. Colloids Surf. B Biointerfaces. 2015;136:729–734. doi: 10.1016/j.colsurfb.2015.10.001. [DOI] [PubMed] [Google Scholar]
  • 30.Haag R., Kratz F. Polymer Therapeutics: Concepts and Applications. Angew. Chem. Int. Ed. 2006;45:1198–1215. doi: 10.1002/anie.200502113. [DOI] [PubMed] [Google Scholar]
  • 31.Ilyasoğlu H., Guo Z. Water soluble chitosan-caffeic acid conjugates as a dual functional polymeric surfactant. Food Biosci. 2019;29:118–125. doi: 10.1016/j.fbio.2019.04.007. [DOI] [Google Scholar]
  • 32.Wang D., Mao L., Dai L., Yuan F., Gao Y. Characterization of chitosan-ferulic acid conjugates and their application in the design of β-carotene bilayer emulsions with propylene glycol alginate. Food Hydrocoll. 2018;80:281–291. doi: 10.1016/j.foodhyd.2017.11.031. [DOI] [Google Scholar]
  • 33.Jing Y., Diao Y., Yu X. Free radical-mediated conjugation of chitosan with tannic acid: Characterization and antioxidant capacity. React. Funct. Polym. 2019;135:16–22. doi: 10.1016/j.reactfunctpolym.2018.12.005. [DOI] [Google Scholar]
  • 34.Cho Y.-S., Lee D.-S., Kim Y.-M., Ahn C.-B., Kim D.-H., Jung W.-K., Je J.-Y. Protection of hepatic cell damage and antimicrobial evaluation of chitosan-catechin conjugate. J. Korean Soc. Appl. Boil. Chem. 2013;56:701–707. doi: 10.1007/s13765-013-3168-8. [DOI] [Google Scholar]
  • 35.Saranya T., Rajan V., Biswas R., Jayakumar R., Sathianarayanan S. Synthesis, characterisation and biomedical applications of curcumin conjugated chitosan microspheres. Int. J. Boil. Macromol. 2018;110:227–233. doi: 10.1016/j.ijbiomac.2017.12.044. [DOI] [PubMed] [Google Scholar]
  • 36.Bhat I.A., Nazir M.I., Ahmad I., Pathakota G.-B., Chanu T., Goswami M., Sundaray J., Sharma R. Fabrication and characterization of chitosan conjugated eurycomanone nanoparticles: In vivo evaluation of the biodistribution and toxicity in fish. Int. J. Boil. Macromol. 2018;112:1093–1103. doi: 10.1016/j.ijbiomac.2018.02.067. [DOI] [PubMed] [Google Scholar]
  • 37.Mu H., Liu Q., Niu H., Sun Y., Duan J. Gold nanoparticles make chitosan–streptomycin conjugates effective towards Gram-negative bacterial biofilm. RSC Adv. 2016;6:8714–8721. doi: 10.1039/C5RA22803D. [DOI] [Google Scholar]
  • 38.Liu Y., Sun Y., He S., Zhu Y., Ao M., Li J., Cao Y. Synthesis and characterization of gibberellin–chitosan conjugate for controlled-release applications. Int. J. Boil. Macromol. 2013;57:213–217. doi: 10.1016/j.ijbiomac.2013.03.024. [DOI] [PubMed] [Google Scholar]
  • 39.Fernandes M.M., Francesko A., Torrent-Burgués J., Tzanov T. Effect of thiol-functionalisation on chitosan antibacterial activity: Interaction with a bacterial membrane model. React. Funct. Polym. 2013;73:1384–1390. doi: 10.1016/j.reactfunctpolym.2013.01.004. [DOI] [Google Scholar]
  • 40.Yuan S., Yin J., Jiang W., Liang B., Pehkonen S., Choong C. Enhancing antibacterial activity of surface-grafted chitosan with immobilized lysozyme on bioinspired stainless steel substrates. Colloids Surf. B Biointerfaces. 2013;106:11–21. doi: 10.1016/j.colsurfb.2012.12.048. [DOI] [PubMed] [Google Scholar]
  • 41.Jalvandi J., White M., Gao Y., Truong Y.B., Padhye R., Kyratzis I.L. Polyvinyl alcohol composite nanofibres containing conjugated levofloxacin-chitosan for controlled drug release. Mater. Sci. Eng. C. 2017;73:440–446. doi: 10.1016/j.msec.2016.12.112. [DOI] [PubMed] [Google Scholar]
  • 42.Pawar V., Dhanka M., Srivastava R. Cefuroxime conjugated chitosan hydrogel for treatment of wound infections. Colloids Surf. B Biointerfaces. 2019;173:776–787. doi: 10.1016/j.colsurfb.2018.10.034. [DOI] [PubMed] [Google Scholar]
  • 43.Basu A., Kunduru K.R., Abtew E., Domb A.J. Polysaccharide-Based Conjugates for Biomedical Applications. Bioconjugate Chem. 2015;26:1396–1412. doi: 10.1021/acs.bioconjchem.5b00242. [DOI] [PubMed] [Google Scholar]
  • 44.Hussain M.A., Abbas K., Jantan I., Bukhari S.N.A. Polysaccharide-based materials in macromolecular prodrug design and development. Int. Mater. Rev. 2017;62:78–98. doi: 10.1080/09506608.2016.1209617. [DOI] [Google Scholar]
  • 45.Woo J.-Y., Je J.-Y. Antioxidant and tyrosinase inhibitory activities of a novel chitosan–phloroglucinol conjugate. Int. J. Food Sci. Technol. 2013;48:1172–1178. doi: 10.1111/ijfs.12071. [DOI] [Google Scholar]
  • 46.Cong Y., Geng J., Wang H., Su J., Arif M., Dong Q., Chi Z., Liu C. Ureido-modified carboxymethyl chitosan-graft-stearic acid polymeric nano-micelles as a targeted delivering carrier of clarithromycin for Helicobacter pylori: Preparation and in vitro evaluation. Int. J. Boil. Macromol. 2019;129:686–692. doi: 10.1016/j.ijbiomac.2019.01.227. [DOI] [PubMed] [Google Scholar]
  • 47.Kim S., Cui Z.-K., Koo B., Zheng J., Aghaloo T., Lee M. Chitosan-Lysozyme Conjugates for Enzyme-Triggered Hydrogel Degradation in Tissue Engineering Applications. ACS Appl. Mater. Interfaces. 2018;10:41138–41145. doi: 10.1021/acsami.8b15591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Dumitriu R.P., Profire L., Nita L.E., Dragostin O.M., Ghetu N., Pieptu D., Vasile C. Sulfadiazine-Chitosan Conjugates and Their Polyelectrolyte Complexes with Hyaluronate Destined to the Management of Burn Wounds. Materials. 2015;8:317–338. doi: 10.3390/ma8010317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Durazzo A., Lucarini M., Souto E.B., Cicala C., Caiazzo E., Izzo A.A., Novellino E., Santini A. Polyphenols: A concise overview on the chemistry, occurrence, and human health. Phytotherapy Res. 2019;33:2221–2243. doi: 10.1002/ptr.6419. [DOI] [PubMed] [Google Scholar]
  • 50.Francisco Javier A.-M., Enrique B.-C., Jose Antonio E., Juan Carlos R.-D., Vicente M. Antimicrobial Capacity of Plant Polyphenols against Gram-positive Bacteria: A Comprehensive Review. Curr. Med. Chem. 2018;25:1–29. [Google Scholar]
  • 51.Sant’Anna V., Biondo E., Kolchinski E.M., da Silva L.F.S., Corrêa A.P.F., Bach E., Brandelli A. Total Polyphenols, Antioxidant, Antimicrobial and Allelopathic Activities of Spend Coffee Ground Aqueous Extract. Waste Biomass Valoriz. 2017;8:439–442. doi: 10.1007/s12649-016-9575-4. [DOI] [Google Scholar]
  • 52.Trošt K., Vodopivec B.M., Lemut M.S., Jug K., Raspor P., Možina S.S., Klančnik A. Polyphenol, antioxidant and antimicrobial potential of six different white and red wine grape processing leftovers. J. Sci. Food Agric. 2016;96:4809–4820. doi: 10.1002/jsfa.7981. [DOI] [PubMed] [Google Scholar]
  • 53.Deng Y., Zhao Y., Padilla-Zakour O., Yang G. Polyphenols, antioxidant and antimicrobial activities of leaf and bark extracts of Solidago canadensis L. Ind. Crop. Prod. 2015;74:803–809. doi: 10.1016/j.indcrop.2015.06.014. [DOI] [Google Scholar]
  • 54.Lee D.-S., Woo J.-Y., Ahn C.-B., Je J.-Y. Chitosan-hydroxycinnamic acid conjugates: Preparation, antioxidant and antimicrobial activity. Food Chem. 2014;148:97–104. doi: 10.1016/j.foodchem.2013.10.019. [DOI] [PubMed] [Google Scholar]
  • 55.Hu Q., Wang T., Zhou M., Xue J., Luo Y. Formation of redispersible polyelectrolyte complex nanoparticles from gallic acid-chitosan conjugate and gum arabic. Int. J. Boil. Macromol. 2016;92:812–819. doi: 10.1016/j.ijbiomac.2016.07.089. [DOI] [PubMed] [Google Scholar]
  • 56.Singh A., Dutta P.K., Kumar H., Kureel A.K., Rai A.K. Improved antibacterial and antioxidant activities of gallic acid grafted chitin-glucan complex. J. Polym. Res. 2019;26:234. doi: 10.1007/s10965-019-1893-3. [DOI] [Google Scholar]
  • 57.Liu J., Lu J.-F., Kan J., Jin C.-H. Synthesis of chitosan-gallic acid conjugate: Structure characterization and in vitro anti-diabetic potential. Int. J. Boil. Macromol. 2013;62:321–329. doi: 10.1016/j.ijbiomac.2013.09.032. [DOI] [PubMed] [Google Scholar]
  • 58.Hu Q., Wang T., Zhou M., Xue J., Luo Y. In Vitro Antioxidant-Activity Evaluation of Gallic-Acid-Grafted Chitosan Conjugate Synthesized by Free-Radical-Induced Grafting Method. J. Agric. Food Chem. 2016;64:5893–5900. doi: 10.1021/acs.jafc.6b02255. [DOI] [PubMed] [Google Scholar]
  • 59.Liu J., Pu H., Chen C., Liu Y., Bai R., Kan J., Jin C. Reaction Mechanisms and Structural and Physicochemical Properties of Caffeic Acid Grafted Chitosan Synthesized in Ascorbic Acid and Hydroxyl Peroxide Redox System. J. Agric. Food Chem. 2018;66:279–289. doi: 10.1021/acs.jafc.7b05135. [DOI] [PubMed] [Google Scholar]
  • 60.Marín A.C., Culcasi M., Cassien M., Stocker P., Thétiot-Laurent S., Robillard B., Chinnici F., Pietri S. Chitosan as an antioxidant alternative to sulphites in oenology: EPR investigation of inhibitory mechanisms. Food Chem. 2019;285:67–76. doi: 10.1016/j.foodchem.2019.01.155. [DOI] [PubMed] [Google Scholar]
  • 61.Saiki S., Nagasawa N., Hiroki A., Morishita N., Tamada M., Muroya Y., Kudo H., Katsumura Y. ESR study on carboxymethyl chitosan radicals in an aqueous solution. Radiat. Phys. Chem. 2010;79:276–278. doi: 10.1016/j.radphyschem.2009.08.043. [DOI] [Google Scholar]
  • 62.Castagnino E., Ottaviani M.F., Cangiotti M., Morelli M., Casettari L., Muzzarelli R.A. Radical scavenging activity of 5-methylpyrrolidinone chitosan and dibutyryl chitin. Carbohydr. Polym. 2008;74:640–647. doi: 10.1016/j.carbpol.2008.04.016. [DOI] [Google Scholar]
  • 63.Jiao W., Shu C., Li X., Cao J., Fan X., Jiang W. Preparation of a chitosan-chlorogenic acid conjugate and its application as edible coating in postharvest preservation of peach fruit. Postharvest Boil. Technol. 2019;154:129–136. doi: 10.1016/j.postharvbio.2019.05.003. [DOI] [Google Scholar]
  • 64.Woranuch S., Yoksan R. Preparation, characterization and antioxidant property of water-soluble ferulic acid grafted chitosan. Carbohydr. Polym. 2013;96:495–502. doi: 10.1016/j.carbpol.2013.04.006. [DOI] [PubMed] [Google Scholar]
  • 65.Netsomboon K., Suchaoin W., Laffleur F., Prüfert F., Bernkop-Schnürch A. Multifunctional adhesive polymers: Preactivated thiolated chitosan-EDTA conjugates. Eur. J. Pharm. Biopharm. 2017;111:26–32. doi: 10.1016/j.ejpb.2016.10.029. [DOI] [PubMed] [Google Scholar]
  • 66.Shrestha A., Hamblin M.R., Kishen A. Characterization of a Conjugate between Rose Bengal and Chitosan for Targeted Antibiofilm and Tissue Stabilization Effects as a Potential Treatment of Infected Dentin. Antimicrob. Agents Chemother. 2012;56:4876–4884. doi: 10.1128/AAC.00810-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Xu R., Ma S., Wu Y., Lee H., Zhou F., Liu W. Adaptive control in lubrication, adhesion, and hemostasis by Chitosan-Catechol-pNIPAM. Biomater. Sci. 2019;7:3599–3608. doi: 10.1039/C9BM00697D. [DOI] [PubMed] [Google Scholar]
  • 68.Hozumi K., Nomizu M. Mixed Peptide-Conjugated Chitosan Matrices as Multi-Receptor Targeted Cell-Adhesive Scaffolds. Int. J. Mol. Sci. 2018;19:2713. doi: 10.3390/ijms19092713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Wang Y., Xie M., Ma G., Fang Y., Yang W., Ma N., Fang D., Hu Q., Pei F. The antioxidant and antimicrobial activities of different phenolic acids grafted onto chitosan. Carbohydr. Polym. 2019;225:115238. doi: 10.1016/j.carbpol.2019.115238. [DOI] [PubMed] [Google Scholar]
  • 70.Quiñones J.P., Szopko R., Schmidt C., Covas C.P. Novel drug delivery systems: Chitosan conjugates covalently attached to steroids with potential anticancer and agrochemical activity. Carbohydr. Polym. 2011;84:858–864. doi: 10.1016/j.carbpol.2010.12.007. [DOI] [Google Scholar]
  • 71.Rui L., Xie M., Hu B., Zhou L., Saeeduddin M., Zeng X. Enhanced solubility and antioxidant activity of chlorogenic acid-chitosan conjugates due to the conjugation of chitosan with chlorogenic acid. Carbohydr. Polym. 2017;170:206–216. doi: 10.1016/j.carbpol.2017.04.076. [DOI] [PubMed] [Google Scholar]
  • 72.Rui L., Xie M., Hu B., Zhou L., Yin D., Zeng X. A comparative study on chitosan/gelatin composite films with conjugated or incorporated gallic acid. Carbohydr. Polym. 2017;173:473–481. doi: 10.1016/j.carbpol.2017.05.072. [DOI] [PubMed] [Google Scholar]
  • 73.Jing Z.-W., Jia Y.-Y., Wan N., Luo M., Huan M.-L., Kang T.-B., Zhou S.-Y., Zhang B.-L. Design and evaluation of novel pH-sensitive ureido-conjugated chitosan/TPP nanoparticles targeted to Helicobacter pylori. Biomaterials. 2016;84:276–285. doi: 10.1016/j.biomaterials.2016.01.045. [DOI] [PubMed] [Google Scholar]
  • 74.Kumar S., Koh J., Kim H., Gupta M., Dutta P. A new chitosan–thymine conjugate: Synthesis, characterization and biological activity. Int. J. Boil. Macromol. 2012;50:493–502. doi: 10.1016/j.ijbiomac.2012.01.015. [DOI] [PubMed] [Google Scholar]
  • 75.Kafedjiiski K., Föger F., Werle M., Bernkop-Schnürch A. Synthesis and in Vitro Evaluation of a Novel Chitosan–Glutathione Conjugate. Pharm. Res. 2005;22:1480–1488. doi: 10.1007/s11095-005-6248-6. [DOI] [PubMed] [Google Scholar]
  • 76.Antony R., Arun T., Manickam S.T.D. A review on applications of chitosan-based Schiff bases. Int. J. Boil. Macromol. 2019;129:615–633. doi: 10.1016/j.ijbiomac.2019.02.047. [DOI] [PubMed] [Google Scholar]
  • 77.Yin X., Chen J., Yuan W., Lin Q., Ji L., Liu F. Preparation and antibacterial activity of Schiff bases from O-carboxymethyl chitosan and para-substituted benzaldehydes. Polym. Bull. 2012;68:1215–1226. doi: 10.1007/s00289-011-0599-4. [DOI] [Google Scholar]
  • 78.Tamer T.M., Hassan M.A., Omer A.M., Baset W.M., Hassan M.E., El-Shafeey M.E., Eldin M.S.M. Synthesis, characterization and antimicrobial evaluation of two aromatic chitosan Schiff base derivatives. Process. Biochem. 2016;51:1721–1730. doi: 10.1016/j.procbio.2016.08.002. [DOI] [Google Scholar]
  • 79.Liu W., Qin Y., Liu S., Xing R., Yu H., Chen X., Li K., Li P. C-coordinated O-carboxymethyl chitosan metal complexes: Synthesis, characterization and antifungal efficacy. Int. J. Boil. Macromol. 2018;106:68–77. doi: 10.1016/j.ijbiomac.2017.07.176. [DOI] [PubMed] [Google Scholar]
  • 80.Liu W., Qin Y., Liu S., Xing R., Yu H., Chen X., Li K., Li P. Synthesis, characterization and antifungal efficacy of C-coordinated O-carboxymethyl chitosan Cu(II) complexes. Carbohydr. Polym. 2017;160:97–105. doi: 10.1016/j.carbpol.2016.12.040. [DOI] [PubMed] [Google Scholar]
  • 81.Wei L., Tan W., Wang G., Li Q., Dong F., Guo Z. The antioxidant and antifungal activity of chitosan derivatives bearing Schiff bases and quaternary ammonium salts. Carbohydr. Polym. 2019;226:115256. doi: 10.1016/j.carbpol.2019.115256. [DOI] [PubMed] [Google Scholar]
  • 82.Li X., Wu P., Cheng S., Lv X. Synthesis and Assessment of Globotriose–Chitosan Conjugate, a Novel Inhibitor of Shiga Toxins Produced byEscherichia coli. J. Med. Chem. 2012;55:2702–2710. doi: 10.1021/jm201570s. [DOI] [PubMed] [Google Scholar]
  • 83.Zhang G., Liu J., Li R., Jiao S., Feng C., Wang Z.A., Du Y. Conjugation of Inulin Improves Anti-Biofilm Activity of Chitosan. Mar. Drugs. 2018;16:151. doi: 10.3390/md16050151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Yang C., Han B., Zheng Y., Liu L., Li C., Sheng S., Zhang J., Wang J., Wu F. The Quality Changes of Postharvest Mulberry Fruit Treated by Chitosan-g-Caffeic Acid during Cold Storage. J. Food Sci. 2016;81:C881–C888. doi: 10.1111/1750-3841.13262. [DOI] [PubMed] [Google Scholar]
  • 85.Zhang A., Mu H., Zhang W., Cui G., Zhu J., Duan J. Chitosan Coupling Makes Microbial Biofilms Susceptible to Antibiotics. Sci. Rep. 2013;3:3364. doi: 10.1038/srep03364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Li R., Yuan X., Wei J., Zhang X., Cheng G., Wang Z.A., Du Y. Synthesis and Evaluation of a Chitosan Oligosaccharide-Streptomycin Conjugate against Pseudomonas aeruginosa Biofilms. Mar. Drugs. 2019;17:43. doi: 10.3390/md17010043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Barbosa M., Vale N., Costa F.M., Martins M.C.L., Gomes P. Tethering antimicrobial peptides onto chitosan: Optimization of azide-alkyne “click” reaction conditions. Carbohydr. Polym. 2017;165:384–393. doi: 10.1016/j.carbpol.2017.02.050. [DOI] [PubMed] [Google Scholar]
  • 88.Kamoun E.A. N-succinyl chitosan–dialdehyde starch hybrid hydrogels for biomedical applications. J. Adv. Res. 2016;7:69–77. doi: 10.1016/j.jare.2015.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Petrin T.H.C., Fadel V., Martins D.B., Dias S.A., Cruz A., Sergio L.M., Arcisio-Miranda M., Castanho M.A.R.B., Cabrera M.P.D.S. Synthesis and Characterization of Peptide-Chitosan Conjugates (PepChis) with Lipid Bilayer Affinity and Antibacterial Activity. Biomacromolecules. 2019;20:2743–2753. doi: 10.1021/acs.biomac.9b00501. [DOI] [PubMed] [Google Scholar]
  • 90.Zampano G., Bertoldo M., Ciardelli F. Defined Chitosan-based networks by C-6-Azide–alkyne “click” reaction. React. Funct. Polym. 2010;70:272–281. doi: 10.1016/j.reactfunctpolym.2010.01.004. [DOI] [Google Scholar]
  • 91.Hu L., Meng X., Xing R., Liu S., Chen X., Qin Y., Yu H., Li P. Design, synthesis and antimicrobial activity of 6- N -substituted chitosan derivatives. Bioorganic Med. Chem. Lett. 2016;26:4548–4551. doi: 10.1016/j.bmcl.2015.08.047. [DOI] [PubMed] [Google Scholar]
  • 92.Luan F., Li Q., Tan W., Wei L., Zhang J., Dong F., Gu G., Guo Z. The evaluation of antioxidant and antifungal properties of 6-amino-6-deoxychitosan in vitro. Int. J. Boil. Macromol. 2018;107:595–603. doi: 10.1016/j.ijbiomac.2017.09.028. [DOI] [PubMed] [Google Scholar]
  • 93.Moussa A., Crépet A., Ladavière C., Trombotto S. Reducing-end “clickable” functionalizations of chitosan oligomers for the synthesis of chitosan-based diblock copolymers. Carbohydr. Polym. 2019;219:387–394. doi: 10.1016/j.carbpol.2019.04.078. [DOI] [PubMed] [Google Scholar]
  • 94.Singh A., Dutta P., Kumar H., Kureel A.K., Rai A.K. Synthesis of chitin-glucan-aldehyde-quercetin conjugate and evaluation of anticancer and antioxidant activities. Carbohydr. Polym. 2018;193:99–107. doi: 10.1016/j.carbpol.2018.03.092. [DOI] [PubMed] [Google Scholar]
  • 95.Da Silva S.B., Krolicka M., Broek L.A.V.D., Frissen A.E., Boeriu C.G. Water-soluble chitosan derivatives and pH-responsive hydrogels by selective C-6 oxidation mediated by TEMPO-laccase redox system. Carbohydr. Polym. 2018;186:299–309. doi: 10.1016/j.carbpol.2018.01.050. [DOI] [PubMed] [Google Scholar]
  • 96.Barbosa M., Costa F., Monteiro C., Duarte F., Martins M.C.L., Gomes P. Antimicrobial coatings prepared from Dhvar-5-click-grafted chitosan powders. Acta Biomater. 2019;84:242–256. doi: 10.1016/j.actbio.2018.12.001. [DOI] [PubMed] [Google Scholar]
  • 97.Gaballah S.T., El-Nazer H.A., Abdel-Monem R.A., El-Liethy M.A., Hemdan B.A., Rabie S.T. Synthesis of novel chitosan-PVC conjugates encompassing Ag nanoparticles as antibacterial polymers for biomedical applications. Int. J. Boil. Macromol. 2019;121:707–717. doi: 10.1016/j.ijbiomac.2018.10.085. [DOI] [PubMed] [Google Scholar]
  • 98.Liu Y., Zhang B., Javvaji V., Kim E., Lee M.E., Raghavan S.R., Wang Q., Payne G.F. Tyrosinase-mediated grafting and crosslinking of natural phenols confers functional properties to chitosan. Biochem. Eng. J. 2014;89:21–27. doi: 10.1016/j.bej.2013.11.016. [DOI] [Google Scholar]
  • 99.Sakai S., Khanmohammadi M., Khoshfetrat A.B., Taya M., Shinji S. Horseradish peroxidase-catalyzed formation of hydrogels from chitosan and poly (vinyl alcohol) derivatives both possessing phenolic hydroxyl groups. Carbohydr. Polym. 2014;111:404–409. doi: 10.1016/j.carbpol.2014.05.010. [DOI] [PubMed] [Google Scholar]
  • 100.Božič M., Gorgieva S., Kokol V. Laccase-mediated functionalization of chitosan by caffeic and gallic acids for modulating antioxidant and antimicrobial properties. Carbohydr. Polym. 2012;87:2388–2398. doi: 10.1016/j.carbpol.2011.11.006. [DOI] [PubMed] [Google Scholar]
  • 101.Aljawish A., Chevalot I., Jasniewski J., Paris C., Scher J., Muniglia L. Laccase-catalysed oxidation of ferulic acid and ethyl ferulate in aqueous medium: A green procedure for the synthesis of new compounds. Food Chem. 2014;145:1046–1054. doi: 10.1016/j.foodchem.2013.07.119. [DOI] [PubMed] [Google Scholar]
  • 102.Božič M., Gorgieva S., Kokol V. Homogeneous and heterogeneous methods for laccase-mediated functionalization of chitosan by tannic acid and quercetin. Carbohydr. Polym. 2012;89:854–864. doi: 10.1016/j.carbpol.2012.04.021. [DOI] [PubMed] [Google Scholar]
  • 103.Sampaio S., Taddei P., Monti P., Buchert J., Freddi G. Enzymatic grafting of chitosan onto Bombyx mori silk fibroin: Kinetic and IR vibrational studies. J. Biotechnol. 2005;116:21–33. doi: 10.1016/j.jbiotec.2004.10.003. [DOI] [PubMed] [Google Scholar]
  • 104.Muzzarelli R.A., Littarru G., Muzzarelli C., Tosi G. Selective reactivity of biochemically relevant quinones towards chitosans. Carbohydr. Polym. 2003;53:109–115. doi: 10.1016/S0144-8617(03)00006-7. [DOI] [Google Scholar]
  • 105.Aljawish A., Chevalot I., Piffaut B., Rondeau-Mouro C., Girardin M., Jasniewski J., Scher J., Muniglia L. Functionalization of chitosan by laccase-catalyzed oxidation of ferulic acid and ethyl ferulate under heterogeneous reaction conditions. Carbohydr. Polym. 2012;87:537–544. doi: 10.1016/j.carbpol.2011.08.016. [DOI] [PubMed] [Google Scholar]
  • 106.Saito H., Sakakibara Y., Sakata A., Kurashige R., Murakami D., Kageshima H., Saito A., Miyazaki Y. Antibacterial activity of lysozyme-chitosan oligosaccharide conjugates (LYZOX) against Pseudomonas aeruginosa, Acinetobacter baumannii and Methicillin-resistant Staphylococcus aureus. PLoS ONE. 2019;14:e0217504. doi: 10.1371/journal.pone.0217504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Kim E., Liu Y., Yang X., Bentley W.E., Payne G.F., Shi X.-W. Biomimetic Approach to Confer Redox Activity to Thin Chitosan Films. Adv. Funct. Mater. 2010;20:2683–2694. doi: 10.1002/adfm.200902428. [DOI] [Google Scholar]
  • 108.Li X., Shi X., Wang M., Du Y. Xylan chitosan conjugate—A potential food preservative. Food Chem. 2011;126:520–525. doi: 10.1016/j.foodchem.2010.11.037. [DOI] [Google Scholar]
  • 109.Liang C., Yuan F., Liu F., Wang Y., Gao Y. Structure and antimicrobial mechanism of ɛ-polylysine–chitosan conjugates through Maillard reaction. Int. J. Boil. Macromol. 2014;70:427–434. doi: 10.1016/j.ijbiomac.2014.07.012. [DOI] [PubMed] [Google Scholar]
  • 110.Song Y.E., Babiker E., Usui M., Saito A., Kato A. Emulsifying properties and bactericidal action of chitosan-lysozyme conjugates. Food Res. Int. 2002;35:459–466. doi: 10.1016/S0963-9969(01)00144-2. [DOI] [Google Scholar]
  • 111.Hofmann T., Bors W., Stettmaier K. Studies on radical intermediates in the early stage of the nonenzymatic browning reaction of carbohydrates and amino acids. J. Agric. Food Chem. 1999;47:379–390. doi: 10.1021/jf980626x. [DOI] [PubMed] [Google Scholar]
  • 112.Berezin A.S., Skorik Y.A. Chitosan-isoniazid conjugates: Synthesis, evaluation of tuberculostatic activity, biodegradability and toxicity. Carbohydr. Polym. 2015;127:309–315. doi: 10.1016/j.carbpol.2015.03.060. [DOI] [PubMed] [Google Scholar]
  • 113.Jing Y., Huang J., Yu X. Preparation, characterization, and functional evaluation of proanthocyanidin-chitosan conjugate. Carbohydr. Polym. 2018;194:139–145. doi: 10.1016/j.carbpol.2018.04.037. [DOI] [PubMed] [Google Scholar]
  • 114.Zhou Z., Chen T., Mei N., Li B., Xu Z., Wang L., Wang X., Tang S. LED 209 conjugated chitosan as a selective antimicrobial and potential anti-adhesion material. Carbohydr. Polym. 2019;206:653–663. doi: 10.1016/j.carbpol.2018.11.044. [DOI] [PubMed] [Google Scholar]
  • 115.Lee D.-S., Je J.-Y. Gallic Acid- Grafted-Chitosan Inhibits Foodborne Pathogens by a Membrane Damage Mechanism. J. Agric. Food Chem. 2013;61:6574–6579. doi: 10.1021/jf401254g. [DOI] [PubMed] [Google Scholar]
  • 116.Kim J.-H., Yu D., Eom S.-H., Kim S.-H., Oh J., Jung W., Kim Y.-M. Synergistic Antibacterial Effects of Chitosan-Caffeic Acid Conjugate against Antibiotic-Resistant Acne-Related Bacteria. Mar. Drugs. 2017;15:167. doi: 10.3390/md15060167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.Zhao L., Hu Y., Xu D., Cai K. Surface functionalization of titanium substrates with chitosan–lauric acid conjugate to enhance osteoblasts functions and inhibit bacteria adhesion. Colloids Surf. B Biointerfaces. 2014;119:115–125. doi: 10.1016/j.colsurfb.2014.05.002. [DOI] [PubMed] [Google Scholar]
  • 118.Yang C., Zhou Y., Zheng Y., Li C., Sheng S., Wang J., Wu F. Enzymatic modification of chitosan by cinnamic acids: Antibacterial activity against Ralstonia solanacearum. Int. J. Boil. Macromol. 2016;87:577–585. doi: 10.1016/j.ijbiomac.2016.03.023. [DOI] [PubMed] [Google Scholar]
  • 119.Amato A., Migneco L.M., Martinelli A., Pietrelli L., Piozzi A., Francolini I. Antimicrobial activity of catechol functionalized-chitosan versus Staphylococcus epidermidis. Carbohydr. Polym. 2018;179:273–281. doi: 10.1016/j.carbpol.2017.09.073. [DOI] [PubMed] [Google Scholar]
  • 120.Xu Y., Fan H., Lu C., Gao G.F., Li X. Synthesis of Galabiose-chitosan Conjugate as Potent Inhibitor of Streptococcus suis Adhesion. Biomacromolecules. 2010;11:1701–1704. doi: 10.1021/bm100289v. [DOI] [PubMed] [Google Scholar]
  • 121.Chatterjee N.S., Panda S.K., Navitha M., Asha K.K., Anandan R., Mathew S. Vanillic acid and coumaric acid grafted chitosan derivatives: Improved grafting ratio and potential application in functional food. J. Food Sci. Technol. 2015;52:7153–7162. doi: 10.1007/s13197-015-1874-4. [DOI] [Google Scholar]
  • 122.Verlee A., Mincke S., Stevens C.V. Recent developments in antibacterial and antifungal chitosan and its derivatives. Carbohydr. Polym. 2017;164:268–283. doi: 10.1016/j.carbpol.2017.02.001. [DOI] [PubMed] [Google Scholar]
  • 123.Zhang H., Li R., Liu W. Effects of Chitin and Its Derivative Chitosan on Postharvest Decay of Fruits: A Review. Int. J. Mol. Sci. 2011;12:917–934. doi: 10.3390/ijms12020917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Raafat D., Sahl H.-G. Chitosan and its antimicrobial potential—a critical literature survey. Microb. Biotechnol. 2009;2:186–201. doi: 10.1111/j.1751-7915.2008.00080.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Molecular Sciences are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES